A temporary reduction in the production of radioisotopes, which are mainly used for diagnosing cancer, including prostate and breast cancer, has been resolved. In October, cancer and heart ...
NorthStar will supply non-carrier added Actinium-225, a radionuclide, for use with Ariceum’s first-in-class radiopharmaceutical drug, satoreotide BELOIT, Wis. & BERLIN--(BUSINESS WIRE)--NorthStar ...
The radioisotope fuel is inserted into the MMRTG at the DOE's Idaho National Laboratory before the MMRTG is shipped to the launch site. Electrically heated versions of the MMRTG are used at JPL to ...
NorthStar will supply non-carrier added Actinium-225, a radionuclide, for use with Ariceum's first-in-class radiopharmaceutical drug, satoreotide Under the terms of the agreement, NorthStar will ...